Customize your JAMA Network experience by selecting one or more topics from the list below.
In the article titled “Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)”1 published online December 3, 2020, in JAMA Oncology, there was incorrect data presented in the Abstract and Results section regarding the number of deaths at 6 months, 6-month OS, and median OS. This article was corrected online.
Data Errors in Abstract and Results Section. JAMA Oncol. 2021;7(3):466. doi:10.1001/jamaoncol.2020.8157
Artificial Intelligence Resource Center